Advertisement
Policy Forum

Policy Forum Policy Forum articles provide a platform for health policy makers from around the world to discuss the challenges and opportunities in improving health care to their constituencies.

See all article types »

The Imperative to Share Clinical Study Reports: Recommendations from the Tamiflu Experience

  • Peter Doshi mail,

    pnd@jhu.edu

    Affiliation: Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America

    X
  • Tom Jefferson,

    Affiliation: The Cochrane Collaboration, Roma, Italy

    X
  • Chris Del Mar

    Affiliation: Centre for Research in Evidence-Based Practice, Bond University, Gold Coast, Australia

    X
  • Published: April 10, 2012
  • DOI: 10.1371/journal.pmed.1001201

About the Authors

Peter Doshi
Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America
Tom Jefferson
The Cochrane Collaboration, Roma, Italy
Chris Del Mar
Centre for Research in Evidence-Based Practice, Bond University, Gold Coast, Australia

Corresponding Author

Email: pnd@jhu.edu

Competing Interests

All review authors have applied for and received competitive research grants. All review authors are co-recipients of a UK National Institute for Health Research grant to carry out a Cochrane review of neuraminidase inhibitors (http://www.hta.ac.uk/2352). In addition: TJ was an ad hoc consultant for F. Hoffman-La Roche Ltd in 1998–1999. TJ receives royalties from his books published by Blackwells and Il Pensiero Scientifico Editore, none of which are on neuraminidase inhibitors. TJ is occasionally interviewed by market research companies for anonymous interviews about Phase 1 or 2 products unrelated to neuraminidase inhibitors. Since submission of this article, TJ has been retained as an expert consultant in a legal case involving Tamiflu. CDM provided expert advice to GlaxoSmithKline about vaccination against acute otitis media in 2008–2009. CDM receives royalties from books published through Blackwells BMJ Books and Elsevier. PD declares no further conflicts of interest.

Author Contributions

Analyzed the data: PD TJ CDM. Wrote the first draft of the manuscript: PD TJ CDM. Contributed to the writing of the manuscript: PD TJ CDM. ICMJE criteria for authorship read and met: PD TJ CDM. Agree with manuscript results and conclusions: PD TJ CDM.